(AMPL) Amplitude - Overview
Stock: Analytics, Session Replay, Experimentation, Activation, Guides
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 60.7% |
| Relative Tail Risk | -8.50% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.73 |
| Alpha | -62.50 |
| Character TTM | |
|---|---|
| Beta | 1.488 |
| Beta Downside | 1.395 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.81% |
| CAGR/Max DD | -0.37 |
Description: AMPL Amplitude January 15, 2026
Amplitude, Inc. (NASDAQ: AMPL) delivers a SaaS-based digital analytics platform that helps product, data, and engineering teams understand and act on user behavior across web and mobile applications.
The core offering includes Amplitude Analytics (real-time behavioral insights), Session Replay (qualitative journey reconstruction), Feature Experimentation (and Web Experimentation to run A/B tests with minimal engineering effort), Activation (which resolves identity conflicts and enables personalized campaign execution), and Guides & Surveys for in-product onboarding and feedback loops.
Amplitude monetizes these tools through subscription contracts, providing implementation, ongoing support, and training services as part of its cloud-delivered solution.
Corporate facts: incorporated in 2011, headquartered in San Francisco, and formerly known as Sonalight, Inc. (name change in Dec 2014). The company operates globally, serving customers in the United States and abroad.
Recent market data (as of FY 2023) shows Amplitude’s revenue at roughly $300 million, a year-over-year growth rate of ~30%, and an annual recurring revenue (ARR) base exceeding $400 million with a reported net dollar retention above 120%. The digital-analytics SaaS sector is expanding at a 12% CAGR, driven by rising e-commerce spend and the need for data-driven product decisions.
For deeper quantitative analysis, you might explore ValueRay’s detailed financial models on AMPL.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -103.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.53 > 1.0 |
| NWC/Revenue: 28.79% < 20% (prev 80.59%; Δ -51.80% < -1%) |
| CFO/TA 0.05 > 3% & CFO 20.1m > Net Income -103.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (131.4m) vs 12m ago 5.66% < -2% |
| Gross Margin: 73.96% > 18% (prev 0.74%; Δ 7322 % > 0.5%) |
| Asset Turnover: 74.66% > 50% (prev 65.65%; Δ 9.02% > 0%) |
| Interest Coverage Ratio: -12.13 > 6 (EBITDA TTM -100.8m / Interest Expense TTM -9.06m) |
Altman Z'' -7.34
| A: 0.22 (Total Current Assets 265.8m - Total Current Liabilities 170.8m) / Total Assets 438.1m |
| B: -1.21 (Retained Earnings -528.7m / Total Assets 438.1m) |
| C: -0.25 (EBIT TTM -109.9m / Avg Total Assets 441.9m) |
| D: -3.00 (Book Value of Equity -528.2m / Total Liabilities 175.9m) |
| Altman-Z'' Score: -7.34 = D |
Beneish M -1.38
| DSRI: 1.05 (Receivables 34.8m/29.3m, Revenue 329.9m/292.5m) |
| GMI: 1.00 (GM 73.96% / 74.23%) |
| AQI: 4.04 (AQ_t 0.34 / AQ_t-1 0.09) |
| SGI: 1.13 (Revenue 329.9m / 292.5m) |
| TATA: -0.28 (NI -103.5m - CFO 20.1m) / TA 438.1m) |
| Beneish M-Score: -1.38 (Cap -4..+1) = D |
What is the price of AMPL shares?
Over the past week, the price has changed by -21.16%, over one month by -36.41%, over three months by -27.04% and over the past year by -41.65%.
Is AMPL a buy, sell or hold?
- StrongBuy: 4
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AMPL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.5 | 114.4% |
| Analysts Target Price | 15.5 | 114.4% |
| ValueRay Target Price | 6.3 | -13.6% |
AMPL Fundamental Data Overview February 03, 2026
P/S = 3.7158
P/B = 4.7769
Revenue TTM = 329.9m USD
EBIT TTM = -109.9m USD
EBITDA TTM = -100.8m USD
Long Term Debt = 3.79m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 2.02m USD (from shortTermDebt, last quarter)
Debt = 3.79m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -78.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.04b USD (1.23b + Debt 3.79m - CCE 189.2m)
Interest Coverage Ratio = -12.13 (Ebit TTM -109.9m / Interest Expense TTM -9.06m)
EV/FCF = 75.28x (Enterprise Value 1.04b / FCF TTM 13.8m)
FCF Yield = 1.33% (FCF TTM 13.8m / Enterprise Value 1.04b)
FCF Margin = 4.19% (FCF TTM 13.8m / Revenue TTM 329.9m)
Net Margin = -31.36% (Net Income TTM -103.5m / Revenue TTM 329.9m)
Gross Margin = 73.96% ((Revenue TTM 329.9m - Cost of Revenue TTM 85.9m) / Revenue TTM)
Gross Margin QoQ = 73.95% (prev 72.60%)
Tobins Q-Ratio = 2.37 (Enterprise Value 1.04b / Total Assets 438.1m)
Interest Expense / Debt = 82.91% (Interest Expense 3.14m / Debt 3.79m)
Taxrate = 21.0% (US default 21%)
NOPAT = -86.8m (EBIT -109.9m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.56 (Total Current Assets 265.8m / Total Current Liabilities 170.8m)
Debt / Equity = 0.01 (Debt 3.79m / totalStockholderEquity, last quarter 262.2m)
Debt / EBITDA = 0.78 (negative EBITDA) (Net Debt -78.4m / EBITDA -100.8m)
Debt / FCF = -5.67 (Net Debt -78.4m / FCF TTM 13.8m)
Total Stockholder Equity = 281.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -23.42% (Net Income -103.5m / Total Assets 438.1m)
RoE = -36.70% (Net Income TTM -103.5m / Total Stockholder Equity 281.9m)
RoCE = -38.45% (EBIT -109.9m / Capital Employed (Equity 281.9m + L.T.Debt 3.79m))
RoIC = -30.78% (negative operating profit) (NOPAT -86.8m / Invested Capital 281.9m)
WACC = 11.36% (E(1.23b)/V(1.23b) * Re(11.40%) + (debt cost/tax rate unavailable))
Discount Rate = 11.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.96%
[DCF Debug] Terminal Value 56.75% ; FCFF base≈13.0m ; Y1≈8.51m ; Y5≈3.88m
Fair Price DCF = 1.23 (EV 48.6m - Net Debt -78.4m = Equity 127.0m / Shares 103.6m; r=11.36% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 12.35 | EPS CAGR: 11.08% | SUE: 0.14 | # QB: 0
Revenue Correlation: 96.47 | Revenue CAGR: 16.83% | SUE: 2.99 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.01 | Chg30d=+0.000 | Revisions Net=+2 | Analysts=10
EPS next Year (2026-12-31): EPS=0.12 | Chg30d=-0.001 | Revisions Net=-1 | Growth EPS=+66.3% | Growth Revenue=+14.0%